Armstrong Advisory Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407 Hold
30
﹤0.01% 964
2026
Q1
$180 Sell
30
-1
-3% -$8 ﹤0.01% 942
2025
Q4
$223 Buy
31
+1
+3% +$8 ﹤0.01% 939
2025
Q3
$321 Hold
30
﹤0.01% 926
2025
Q2
$291 Hold
30
﹤0.01% 909
2025
Q1
$448 Hold
30
﹤0.01% 824
2024
Q4
$448 Hold
30
﹤0.01% 824
2024
Q3
$574 Hold
30
﹤0.01% 765
2024
Q2
$621 Hold
30
﹤0.01% 768
2024
Q1
$433 Hold
30
﹤0.01% 752
2023
Q4
$433 Hold
30
﹤0.01% 752
2023
Q3
$521 Hold
30
﹤0.01% 814
2023
Q2
$625 Hold
30
﹤0.01% 776
2023
Q1
$706 Sell
30
-13
-30% -$349 ﹤0.01% 750
2022
Q4
$1.2K Buy
+43
New +$1.1K ﹤0.01% 763

Other funds holding OGN

Armstrong Advisory Group's OGN Position: Q2 2026 in Review

Armstrong Advisory Group held its Organon & Co (OGN) position steady in Q2 2026 at 30 shares worth $407. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Armstrong Advisory Group first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.2K in Q4 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Armstrong Advisory Group held 30 shares of Organon & Co worth $407 as of Q2 2026.
  • Armstrong Advisory Group left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #964 holding.
  • Armstrong Advisory Group first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Organon & Co position peaked at $1.2K in Q4 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.